Desmoplastic Small Round Cell Tumors clinical trials at UCLA
1 in progress, 0 open to eligible people
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Sorry, in progress, not accepting new patients
This study is being conducted to test the safety and efficacy of ramucirumab in combination with other chemotherapy in the treatment of relapsed, recurrent, or refractory desmoplastic small round cell tumor (DSRCT) in children and young adults. This trial is part of the CAMPFIRE master protocol (NCT05999994) which is a platform to accelerate the development of new treatments for pediatric and young adult participants with cancer. Your participation in this trial could last 12 months or longer, depending on how you and your tumor respond.
Los Angeles, California and other locations
Our lead scientists for Desmoplastic Small Round Cell Tumors research studies include Noah Federman.